期刊文献+

男性乳腺癌的内分泌治疗 被引量:1

原文传递
导出
摘要 与女性乳腺癌相比,男性乳腺癌(male breast cancer,MBC)的发病率及关注度相对较低。在美国,每年MBC的发病率占所有乳腺癌的0.5%~1%[1],发病率逐年上升[2]。国外研究显示,MBC平均发病年龄较女性发病年龄高,MBC发病年龄为(59.8±9.5)岁[3],呈单峰分布,高峰年龄为71岁[4]。目前,X线摄影为诊断男性早期乳腺癌的有效方法,敏感度高达92%,
出处 《中华乳腺病杂志(电子版)》 CAS CSCD 2015年第5期334-336,共3页 Chinese Journal of Breast Disease(Electronic Edition)
  • 相关文献

参考文献30

  • 1Ruddy KJ, Winer EP. Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship [ J]. Ann 0ncol,2013,24 (6) : 1434-1443.
  • 2Chavez-Macgregor M, Clarke CA, Lichtensztajn D, et al. Male breast cancer according to tumor subtype and race : a population- based study[J]. Cancer, 2013, 119(9): 1611-1617.
  • 3Serarslan A, Gursel B, Okumus NO, et al. Male breast cancer: 20 years experience of a Tertiary Hospital from the Middle Black Sea Region of Turkey [ J ]. Asian Pac J Cancer Prey,2015,16(15) : 6673-6679.
  • 4李林,朱明智,邱新光.男性乳腺癌前哨淋巴结活检11例分析[J].国际外科学杂志,2015,42(3):171-173. 被引量:4
  • 5Gradishar WJ, Anderson BO, Balassanian R, et al. Breast cancer version 2. 2015 [ J]. J Natl Compr Canc Netw, 2015, 13(4) : 448-475.
  • 6Sipetic-Grujicic SB, Murtezani ZH, Neskovic-Konstatinovic ZB, et al. Multivariate analysis of prognostic factors in male breast cancer in Serbia [ J 1. Asian Pac J Cancer Prey, 2014, 15(7) :3233-3238.
  • 7宋健,李荣国,赵悦,张东伟.男性乳腺癌的诊治现状[J].临床外科杂志,2014,22(10):787-789. 被引量:4
  • 8Nilsson C, Johansson I, Ahlin C, et al. Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact[ J]. Acta Oncol, 2013, 52 ( 1 ) : 102-109.
  • 9Sousa B, Moser E, Cardoso F. An update on male breast cancer and future directions for research and treatment [ J]. Eur J Pharmaco1,2013,717 ( 1-3 ) :71-83.
  • 10钟颖,孙强,周易冬,茅枫,关竞红,林燕,徐雅莉.晚期乳腺癌患者的内分泌治疗[J].中华乳腺病杂志(电子版),2015,9(2):45-46. 被引量:3

二级参考文献51

  • 1李宏,姜继勇.他莫昔芬与子宫内膜癌[J].国外医学(妇产科学分册),2005,32(3):189-191. 被引量:4
  • 2高婉丽,冯力民,王伟娟,李晶华,刘小春.绝经后乳腺癌患者服用他莫昔芬发生子宫内膜息肉危险因素的探讨[J].现代妇产科进展,2005,14(4):289-292. 被引量:6
  • 3杜伟亚,苏逢锡,于萍,黄经光.早期乳腺癌前哨淋巴结的临床研究[J].中国基层医药,2005,12(8):1063-1064. 被引量:1
  • 4王敏,惠京.他莫昔芬对子宫内膜细胞的影响及其作用机制[J].国外医学(妇产科学分册),2007,34(1):66-69. 被引量:4
  • 5陈新谦,金有豫,汤光.新编药物学[M].第17版.北京:人民卫生出版社,2011.81.
  • 6Wilder JL, Shajahan S, Khattar NH, et al.Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study[J], Gynecol Oncol, 2004, 92(2): 553-558.
  • 7Cohen I. Endometrial pathologies associated with postmenopausal tamoxifen treatment[J]. Gynecol Oncol, 2004, 94(2): 256-266.
  • 8Fung MF, Reid A, Faught W, et al. Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen[J]. Gynecol Oncol, 2003, 91:154-159.
  • 9Cohen I, Azaria R, Bernheim J, et al. Risk factors of endometrial polyps resected from postmenopausal patients with breast carcinoma treated with tamoxifen[J]. Cancer, 2001, 92(5): 1151 - 1155.
  • 10Egawa T, Toda K, Nemoto Y, et al. Pitavastatin ameliorates severe hepatic steatosis in aromatase-deficient(Ar-/-) mice[J]. Lipids, 2003, 38(5): 519-523.

共引文献29

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部